FALVEY MICHAEL 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 13, 2017
Insider Transaction Report
Form 4
FALVEY MICHAEL
EVP, CFO & Treasurer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2017-09-11+125,000→ 125,000 totalExercise: $10.60Exp: 2027-09-10→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 11, 2017. The shares underlying this option vest as to 25% of the shares on September 11, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter.